COMBATING EARLY MENOPAUSE: MODERN MEDICAL APPROACHES AND NATURAL TREATMENT METHODS

Аннотация

This article explores contemporary strategies for managing early menopause, examining both conventional medical interventions and complementary natural approaches. Through analysis of current literature, the paper reviews hormone replacement therapy protocols, innovative fertility preservation techniques, and emerging pharmacological treatments alongside evidence-based natural interventions including phytoestrogens, lifestyle modifications, and psychological support methods. The findings highlight the importance of personalized, integrative care combining medical and natural approaches for optimal management of early menopause, emphasizing the need for comprehensive treatment strategies that address both physical symptoms and psychological wellbeing. Keywords: early menopause, premature ovarian insufficiency, hormone replacement therapy, fertilitypreservation, phytoestrogens, integrative medicine, lifestyle interventions Introduction. Early menopause, defined as the permanent cessation of menstruation before age 45, affects approximately 5% of women globally, with premature ovarian insufficiency (POI) occurring in 1% of women under 40 [1]. This condition results in estrogen deficiency decades earlier than anticipated, presenting significant challenges for affected women's physical and psychological wellbeing. The premature loss of ovarian function not only disrupts reproductive plans but also increases risks for cardiovascular disease, osteoporosis, cognitivedecline, and psychosocial distress [2]. Management approaches for early menopause have evolved significantly in recent decades, with conventional medicine offering increasingly sophisticated hormonal and fertility preservation options. Simultaneously, growing interest in complementary and alternative medicine has expanded the range of natural interventions available to women seeking to manage symptoms and mitigate health risks [3]. Despite these advances, many women report dissatisfaction with conventional treatments alone and express interest in integrative approaches that combineevidence-based medical and natural strategies. This article aims to review current medical approaches and natural treatment methods for early menopause, analyzing their efficacy, safety profiles, and potential for complementary use in comprehensive management protocols. By examining both conventional and natural interventions through an evidence-based lens, this review seeks to provide healthcare professionals with balanced information to guide personalized treatment recommendations forwomen experiencing early menopause. Main Section. The cornerstone of conventional medical management for early menopause remains hormone replacement therapy (HRT). Unlike postmenopausal women, those with early menopause generally have a favorable risk-benefit profile for HRT use until at least the average age of natural menopause (51 years) [4]. Contemporary HRT regimens typically employ 17β-estradiol via transdermal or oral routes, combined with cyclical or continuous progestogen for women with an intact uterus. The transdermal route offers advantages page56 INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE ISSN:2692-5206,ImpactFactor:12,23 AmericanAcademicpublishers,volume05,issue05,2025 Journal: https://www.academicpublishers.org/journals/index.php/ijai including bypass of first-pass liver metabolism, reduced thrombotic risk, and more stable hormone levels [3]. Recent innovations include development of tissue-selective estrogen complexes and lower-dose formulations that maintain efficacy while potentially reducing adverse effects [5]. For women with early menopause seeking fertility, assisted reproductive technologies have transformed possibilities for family building. Oocyte donation represents the most established and successful approach, with success rates largely independent of recipient age [6]. For those diagnosed with impending ovarian insufficiency, fertility preservation through oocyte or embryo cryopreservation before complete follicular depletion provides an opportunity to maintain genetic parenthood. Emerging experimental approaches include in vitro activation of residual follicles, ovarian tissue cryopreservation and transplantation, and stem cell-based therapies aimingto regenerateovarian function [2]. Beyond hormonal and fertility interventions, conventional medicine addresses comorbidities and symptom management. Bisphosphonates, selective estrogen receptor modulators, and RANKL inhibitors provide alternatives for bone protection when HRT is contraindicated. Antidepressants, particularly selective serotonin reuptake inhibitors and serotonin- norepinephrine reuptake inhibitors, may alleviate vasomotor symptoms and mood disturbances, though with generally lower efficacy than HRT [7]. Natural approaches to early menopause management have gained substantial attention as complementary strategies. Phytoestrogens, plant-derived compounds with structural similarity to estradiol, repres